
Agreement - October 20, 2021
Atlas Antibodies enters agreement with T-Cure Bioscience
The two companies have announced a collaborative agreement for the development, manufacture, and supply of CT83 (KK-LC-1) mAb. These will be used to develop a diagnostic test to identify tumors that express KK-LC-1. Patients with KK-LC-1 positive tumors may be eligible inclusion in clinical trials of a KK-LC-1 targeted T-Cell therapy, state the companies. “We […]